The anti-TB activity of new thiazole–imidazo[2,1- b ][1,3,4]thiadiazoles, which are synthesized via one-pot synthesis, is comparable with that of standard drugs.
No takes yet. Share an insight, caveat, or question.
Ramprasad et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: